EU
GBT

Emory University’s Global Blood Therapeutics, Inc. GBT Stock Holding History

Emory University’s Portfolio GBT Stock Details GBT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-39,349
Closed -$2.07M – 44
2019
Q2 		$2.07M Sell
39,349
-6,422
-14% -$369K 1.46% 27
2019
Q1 		$2.42M Sell
45,771
-16,872
-27% -$829K 1.7% 20
2018
Q4 		$2.57M Buy
62,643
+8,692
+16% +$326K 2.03% 6
2018
Q3 		$2.05M Sell
53,951
-366
-0.7% -$16.2K 1.34% 39
2018
Q2 		$2.46M Buy
54,317
+12,707
+31% +$579K 1.63% 23
2018
Q1 		$2.01M Sell
41,610
-3,831
-8% -$214K 1.44% 35
2017
Q4 		$1.79M Sell
45,441
-10,716
-19% -$400K 1.53% 33
2017
Q3 		$1.74M Buy
56,157
+3,448
+7% +$97K 1.38% 24
2017
Q2 		$1.44M Buy
+52,709
New +$1.57M 1.27% 45

Other funds holding GBT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

Emory University's GBT Position: Q3 2019 in Review

Emory University sold out of Global Blood Therapeutics, Inc. (GBT) in Q3 2019, closing a stake of 39,349 shares — an estimated $2.07M sold.

Emory University first reported a position in GBT in Q2 2017 and held it in 9 quarters. The position peaked at $2.57M in Q4 2018. 208 funds tracked by Wall St. Rank hold GBT as of Q3 2019.

  • Emory University reported no remaining Global Blood Therapeutics, Inc. position as of Q3 2019 after selling out during the quarter.
  • Emory University sold 39,349 Global Blood Therapeutics, Inc. shares in Q3 2019, an estimated $2.07M.
  • Emory University first reported a position in Global Blood Therapeutics, Inc. in Q2 2017 and held it in 9 quarters.
  • Emory University's Global Blood Therapeutics, Inc. position peaked at $2.57M in Q4 2018.
  • 208 funds tracked by Wall St. Rank held Global Blood Therapeutics, Inc. as of Q3 2019.

Based on Emory University's 13F filing for Q3 2019, filed 14 Nov 2019.